Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

This study has been terminated.
(Gallium is no longer available for the conduct of this study.)
Sponsor:
Collaborator:
Genta Incorporated
Information provided by (Responsible Party):
Loyola University
ClinicalTrials.gov Identifier:
NCT00836173
First received: February 3, 2009
Last updated: October 29, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)